Fundies.
English

Segment disclosures

Company overview

Bionano Genomics, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 16 retained observations 11 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bngo:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-308171000 USD20260810Open filing evidence
2026-01-01 – 2026-06-3014858000 USD20260810Open filing evidence
2026-01-01 – 2026-03-316687000 USD20260513Open filing evidence
2025-01-01 – 2025-12-3128508000 USD20260323Open filing evidence
2025-07-01 – 2025-09-307367000 USD20251113Open filing evidence
2025-01-01 – 2025-09-3020557000 USD20251113Open filing evidence
2025-04-01 – 2025-06-306733000 USD20260810Open filing evidence
2025-01-01 – 2025-06-3013190000 USD20260810Open filing evidence
2025-01-01 – 2025-03-316457000 USD20260513Open filing evidence
2024-01-01 – 2024-12-3130776000 USD20260323Open filing evidence
2024-07-01 – 2024-09-306073000 USD20251113Open filing evidence
2024-01-01 – 2024-09-3022613000 USD20251113Open filing evidence
2024-04-01 – 2024-06-307771000 USD20250814Open filing evidence
2024-01-01 – 2024-06-3016540000 USD20250814Open filing evidence
2024-01-01 – 2024-03-318769000 USD20250514Open filing evidence
2023-01-01 – 2023-12-3136116000 USD20250331Open filing evidence